{\rtf1\ansi\landscape\paperh12240\paperw15840\margl1440\margr1440\margt1440\margb1440\psz1{\colortbl\red0\green0\blue0;\red255\green255\blue255;\red221\green221\blue221;}{\fonttbl\f0\fcharset0\fnil Arial;\f1\fcharset0\fnil Times New Roman;\f2\fcharset0\fnil Arial;\f3\fcharset0\fnil Arial;\f4\fcharset0\fnil Arial;}\pard\plain\sb60\tx90{\plain\fs40\f1\cf0\cb1 Reagent Dispense History{\fs47\par}}\pard\plain\sb37\tx90\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12960{\plain\fs16\b\f2\cf0\cb2 ID\plain\tab\fs16\b\f2\cf0\cb2 Lot\plain\tab\fs16\b\f2\cf0\cb2 Project\plain\tab\fs16\b\f2\cf0\cb2 Requestor\plain\tab\fs16\b\f2\cf0\cb2 Requested\plain\tab\fs16\b\f2\cf0\cb2 Purpose\plain\tab\fs16\b\f2\cf0\cb2 Delivered\plain\tab\fs16\b\f2\cf0\cb2 Dispenser\plain\tab\fs16\b\f2\cf0\cb2 Amt(mg){\fs20\par}}\pard\plain\sb1\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 83\plain\tab\fs18\f3\cf0\cb1 A-765865.0\plain\tab\fs18\f3\cf0\cb1 D2E7{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1311710\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 01/26/2006\plain\tab\fs18\f3\cf0\cb1 Large-scale F(ab) generation\plain\tab\fs18\f3\cf0\cb1 02/10/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 20{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1311710\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 TARCSEX\plain\tab\fs18\f3\cf0\cb1 03/06/2006\plain\tab\fs18\f3\cf0\cb1 Humira Inhalation study PK analysis\plain\tab\fs18\f3\cf0\cb1 03/07/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1311710\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BAJARAC\plain\tab\fs18\f3\cf0\cb1 12/12/2005\plain\tab\fs18\f3\cf0\cb1 IL-1ab\plain\tab\fs18\f3\cf0\cb1 12/13/2005\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 0.677{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 21.677{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 45\plain\tab\fs18\f3\cf0\cb1 A-796147.0\plain\tab\fs18\f3\cf0\cb1 125-2H mu IgG1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1276664\plain\tab\fs18\f3\cf0\cb1 ANTI IL-18 MAB\plain\tab\fs18\f3\cf0\cb1 BRYANSH\plain\tab\fs18\f3\cf0\cb1 12/22/2005\plain\tab\fs18\f3\cf0\cb1 CIA-137 combo\plain\tab\fs18\f3\cf0\cb1 01/03/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 28{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1276664\plain\tab\fs18\f3\cf0\cb1 ANTI IL-18 MAB\plain\tab\fs18\f3\cf0\cb1 GOESSC\plain\tab\fs18\f3\cf0\cb1 01/06/2006\plain\tab\fs18\f3\cf0\cb1 Control reagent for anti-CXCL13 MAB \plain\tab\fs18\f3\cf0\cb1 01/12/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 10{\fs23\par}}\pard\plain\tx6240{\plain\tab\fs18\f3\cf0\cb1 studies{\fs20\par}}\pard\plain\sb81\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 38{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 119\plain\tab\fs18\f3\cf0\cb1 A-796874.0\plain\tab\fs18\f3\cf0\cb1 J695{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1313235\plain\tab\fs18\f3\cf0\cb1 ANTI IL-12 (BD ILS999)\plain\tab\fs18\f3\cf0\cb1 WISCHEM\plain\tab\fs18\f3\cf0\cb1 02/17/2006\plain\tab\fs18\f3\cf0\cb1 02/15/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1313235\plain\tab\fs18\f3\cf0\cb1 ANTI IL-12 (BD ILS999)\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 12/05/2005\plain\tab\fs18\f3\cf0\cb1 IL-23 BioAssay, per Erik M Wischhof\plain\tab\fs18\f3\cf0\cb1 12/06/2005\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 39\plain\tab\fs18\f3\cf0\cb1 A-799538.0\plain\tab\fs18\f3\cf0\cb1 hu IgG1/K{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1330424\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BAJARAC\plain\tab\fs18\f3\cf0\cb1 12/12/2005\plain\tab\fs18\f3\cf0\cb1 IL-1ab\plain\tab\fs18\f3\cf0\cb1 12/13/2005\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 44\plain\tab\fs18\f3\cf0\cb1 A-803296.0\plain\tab\fs18\f3\cf0\cb1 1C5 mu IgG2a/k wt{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1274240\plain\tab\fs18\f3\cf0\cb1 ANTI IL-18 MAB\plain\tab\fs18\f3\cf0\cb1 BRYANSH\plain\tab\fs18\f3\cf0\cb1 12/22/2005\plain\tab\fs18\f3\cf0\cb1 CIA-138 combo\plain\tab\fs18\f3\cf0\cb1 01/13/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 28{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1274240\plain\tab\fs18\f3\cf0\cb1 ANTI IL-18 MAB\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 12/28/2005\plain\tab\fs18\f3\cf0\cb1 LC-MS & SEC-HPLC for COT completion\plain\tab\fs18\f3\cf0\cb1 01/04/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 28.5{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 76\plain\tab\fs18\f3\cf0\cb1 A-834443.0\plain\tab\fs18\f3\cf0\cb1 9H10.C2.E2 mu IgG1/K wt{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1227132\plain\tab\fs18\f3\cf0\cb1 ANTI IL-1 ALPHA/BETA\plain\tab\fs18\f3\cf0\cb1 MCCARD\plain\tab\fs18\f3\cf0\cb1 01/17/2006\plain\tab\fs18\f3\cf0\cb1 01/18/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 20{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1227132\plain\tab\fs18\f3\cf0\cb1 ANTI IL-1 ALPHA/BETA\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 12/07/2005\plain\tab\fs18\f3\cf0\cb1 CRO Study\plain\tab\fs18\f3\cf0\cb1 12/07/2005\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 30{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 50{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 112\plain\tab\fs18\f3\cf0\cb1 A-835496.0\plain\tab\fs18\f3\cf0\cb1 murine TNFa-biotin{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1282832\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 KALGHLK\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 MSD assay development\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 SWENSJ\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 55\plain\tab\fs18\f3\cf0\cb1 A-846166.0\plain\tab\fs18\f3\cf0\cb1 Y13-238{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1244590\plain\tab\fs18\f3\cf0\cb1 CD19\plain\tab\fs18\f3\cf0\cb1 GOESSC\plain\tab\fs18\f3\cf0\cb1 01/09/2006\plain\tab\fs18\f3\cf0\cb1 Control for 1D3\plain\tab\fs18\f3\cf0\cb1 01/13/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 10{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1354706\plain\tab\fs18\f3\cf0\cb1 CD19\plain\tab\fs18\f3\cf0\cb1 BOUSQPF\plain\tab\fs18\f3\cf0\cb1 01/12/2006\plain\tab\fs18\f3\cf0\cb1 CXCL13 control experiment\plain\tab\fs18\f3\cf0\cb1 01/13/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 17{\fs23\par}}\pard\plain\sb256\tx90\tqr\tx12960{\plain\tab\fs16\f4\cf0\cb1 Friday, March 10, 2006\plain\tab\fs16\f4\cf0\cb1 Page 1 of 5{\fs20\par}}{\page}\pard\plain\sb60\tx90\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12960{\plain\fs16\b\f2\cf0\cb2 ID\plain\tab\fs16\b\f2\cf0\cb2 Lot\plain\tab\fs16\b\f2\cf0\cb2 Project\plain\tab\fs16\b\f2\cf0\cb2 Requestor\plain\tab\fs16\b\f2\cf0\cb2 Requested\plain\tab\fs16\b\f2\cf0\cb2 Purpose\plain\tab\fs16\b\f2\cf0\cb2 Delivered\plain\tab\fs16\b\f2\cf0\cb2 Dispenser\plain\tab\fs16\b\f2\cf0\cb2 Amt(mg){\fs20\par}}\pard\plain\sb61\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 27{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 104\plain\tab\fs18\f3\cf0\cb1 A-846889.0\plain\tab\fs18\f3\cf0\cb1 8C11-1E10{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 MATHISL\plain\tab\fs18\f3\cf0\cb1 02/07/2006\plain\tab\fs18\f3\cf0\cb1 CIA-143 pos. control\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 SWENSJ\plain\tab\fs18\f3\cf0\cb1 22{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 HUELSRM\plain\tab\fs18\f3\cf0\cb1 12/01/2005\plain\tab\fs18\f3\cf0\cb1 testing in asthma model\plain\tab\fs18\f3\cf0\cb1 12/01/2005\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 12{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 HUBBASN\plain\tab\fs18\f3\cf0\cb1 02/02/2006\plain\tab\fs18\f3\cf0\cb1 IL-13  4.54mg/ml concentration, three 1 \plain\tab\fs18\f3\cf0\cb1 02/03/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 12{\fs23\par}}\pard\plain\tx6240{\plain\tab\fs18\f3\cf0\cb1 ml vials{\fs20\par}}\pard\plain\sb21\tx540\tx1500\tx3915\tx4896\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BUTLEDH\plain\tab\fs18\f3\cf0\cb1 01/12/2006\plain\tab\fs18\f3\cf0\cb1 01/16/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 12{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 NELSOC\plain\tab\fs18\f3\cf0\cb1 01/09/2006\plain\tab\fs18\f3\cf0\cb1 01/06/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 75{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BUTLEDH\plain\tab\fs18\f3\cf0\cb1 02/09/2006\plain\tab\fs18\f3\cf0\cb1 p38 project\plain\tab\fs18\f3\cf0\cb1 02/10/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 12{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 HUELSRM\plain\tab\fs18\f3\cf0\cb1 12/14/2005\plain\tab\fs18\f3\cf0\cb1 PK and RAHA/MAMA\plain\tab\fs18\f3\cf0\cb1 12/22/2005\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 4{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1299103\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BARLOEH\plain\tab\fs18\f3\cf0\cb1 02/16/2006\plain\tab\fs18\f3\cf0\cb1 anti-id immunogen\plain\tab\fs18\f3\cf0\cb1 02/17/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 154{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 136\plain\tab\fs18\f3\cf0\cb1 A-850651.0\plain\tab\fs18\f3\cf0\cb1 C8.6.2 mu IgG1 WT{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1251319\plain\tab\fs18\f3\cf0\cb1 ANTI-IL-12 (BACKUP)\plain\tab\fs18\f3\cf0\cb1 WISCHEM\plain\tab\fs18\f3\cf0\cb1 03/06/2006\plain\tab\fs18\f3\cf0\cb1 in vitro bioassay\plain\tab\fs18\f3\cf0\cb1 03/07/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 94\plain\tab\fs18\f3\cf0\cb1 A-850652.0\plain\tab\fs18\f3\cf0\cb1 IL-12 hu{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1251320\plain\tab\fs18\f3\cf0\cb1 ANTI IL-12 (BD ILS999)\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 Requested by Brockman of Germany: \plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 5{\fs23\par}}\pard\plain\tx6240{\plain\tab\fs18\f3\cf0\cb1 PK-ELISA{\fs20\par}}\pard\plain\sb21\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1339493\plain\tab\fs18\f3\cf0\cb1 ANTI IL-12 (BD ILS999)\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 Binding Ability for the week of 02/06/06\plain\tab\fs18\f3\cf0\cb1 02/09/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.454{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 5.454{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 33\plain\tab\fs18\f3\cf0\cb1 A-864849.0\plain\tab\fs18\f3\cf0\cb1 recombinant hIL-1a{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1328996\plain\tab\fs18\f3\cf0\cb1 ANTI IL-1 ALPHA/BETA\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 12/07/2005\plain\tab\fs18\f3\cf0\cb1 Biotinylation\plain\tab\fs18\f3\cf0\cb1 12/07/2005\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 129\plain\tab\fs18\f3\cf0\cb1 A-867085.0\plain\tab\fs18\f3\cf0\cb1 1B7.11 mu IgG1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1309591\plain\tab\fs18\f3\cf0\cb1 ANTI IL-1 ALPHA/BETA\plain\tab\fs18\f3\cf0\cb1 HUBBASN\plain\tab\fs18\f3\cf0\cb1 02/24/2006\plain\tab\fs18\f3\cf0\cb1 IL-13 induced asthma model\plain\tab\fs18\f3\cf0\cb1 02/24/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 8{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1309591\plain\tab\fs18\f3\cf0\cb1 ANTI IL-1 ALPHA/BETA\plain\tab\fs18\f3\cf0\cb1 HUBBASN\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 Control for in vivo astma model\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 5.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 13.5{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 130\plain\tab\fs18\f3\cf0\cb1 A-899077.0\plain\tab\fs18\f3\cf0\cb1 C17.8 ra IgG2a WT{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1313096\plain\tab\fs18\f3\cf0\cb1 ANTI IL-12 (BD ILS999)\plain\tab\fs18\f3\cf0\cb1 ZHONGSX\plain\tab\fs18\f3\cf0\cb1 03/01/2006\plain\tab\fs18\f3\cf0\cb1 mIL23 MAb counter screening\plain\tab\fs18\f3\cf0\cb1 03/02/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 6{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1313096\plain\tab\fs18\f3\cf0\cb1 ANTI IL-12 (BD ILS999)\plain\tab\fs18\f3\cf0\cb1 WISCHEM\plain\tab\fs18\f3\cf0\cb1 02/23/2006\plain\tab\fs18\f3\cf0\cb1 In vitro IL-23 Bio-assay\plain\tab\fs18\f3\cf0\cb1 02/24/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1313096\plain\tab\fs18\f3\cf0\cb1 ANTI IL-12 (BD ILS999)\plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 01/10/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 6.6{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 133\plain\tab\fs18\f3\cf0\cb1 A-901968.0\plain\tab\fs18\f3\cf0\cb1 Enbrel (Etanercept){\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1316937\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 KALGHLK\plain\tab\fs18\f3\cf0\cb1 03/06/2006\plain\tab\fs18\f3\cf0\cb1 MOA studies\plain\tab\fs18\f3\cf0\cb1 03/08/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 25{\fs23\par}}\pard\plain\sb90\tx90\tqr\tx12960{\plain\tab\fs16\f4\cf0\cb1 Friday, March 10, 2006\plain\tab\fs16\f4\cf0\cb1 Page 2 of 5{\fs20\par}}{\page}\pard\plain\sb60\tx90\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12960{\plain\fs16\b\f2\cf0\cb2 ID\plain\tab\fs16\b\f2\cf0\cb2 Lot\plain\tab\fs16\b\f2\cf0\cb2 Project\plain\tab\fs16\b\f2\cf0\cb2 Requestor\plain\tab\fs16\b\f2\cf0\cb2 Requested\plain\tab\fs16\b\f2\cf0\cb2 Purpose\plain\tab\fs16\b\f2\cf0\cb2 Delivered\plain\tab\fs16\b\f2\cf0\cb2 Dispenser\plain\tab\fs16\b\f2\cf0\cb2 Amt(mg){\fs20\par}}\pard\plain\sb1\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1316937\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 01/26/2006\plain\tab\fs18\f3\cf0\cb1 Large-scale F(ab) generation\plain\tab\fs18\f3\cf0\cb1 02/10/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 20{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1316937\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BAJARAC\plain\tab\fs18\f3\cf0\cb1 12/12/2005\plain\tab\fs18\f3\cf0\cb1 IL-1ab\plain\tab\fs18\f3\cf0\cb1 12/19/2005\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 45.5{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 116\plain\tab\fs18\f3\cf0\cb1 A-901969.0\plain\tab\fs18\f3\cf0\cb1 Remicade (Infliximab){\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1316939\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 02/10/2006\plain\tab\fs18\f3\cf0\cb1 F(ab) generation-Large Scale\plain\tab\fs18\f3\cf0\cb1 02/14/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 20{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1326524\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BAJARAC\plain\tab\fs18\f3\cf0\cb1 12/12/2005\plain\tab\fs18\f3\cf0\cb1 IL-1ab\plain\tab\fs18\f3\cf0\cb1 12/19/2005\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 20.5{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 40\plain\tab\fs18\f3\cf0\cb1 A-903701.0\plain\tab\fs18\f3\cf0\cb1 MAB210 mu IgG1/K wt{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1319586\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 12/14/2005\plain\tab\fs18\f3\cf0\cb1 D2E7 MOA-RBA method development\plain\tab\fs18\f3\cf0\cb1 12/19/2005\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 8.42{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 8.42{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 131\plain\tab\fs18\f3\cf0\cb1 A-905245.0\plain\tab\fs18\f3\cf0\cb1 Recombinant Human IL-13 Wt (213-IL/CF){\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1363379\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 03/01/2006\plain\tab\fs18\f3\cf0\cb1 Biacore evaluation\plain\tab\fs18\f3\cf0\cb1 03/02/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 0.2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1363379\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 BOSESX\plain\tab\fs18\f3\cf0\cb1 03/03/2006\plain\tab\fs18\f3\cf0\cb1 For Biacore testing of 4 different \plain\tab\fs18\f3\cf0\cb1 03/07/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 1.2{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 73\plain\tab\fs18\f3\cf0\cb1 A-920646.0\plain\tab\fs18\f3\cf0\cb1 recombinant mIL-1 alpha{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1342907\plain\tab\fs18\f3\cf0\cb1 ANTI IL-1 ALPHA/BETA\plain\tab\fs18\f3\cf0\cb1 HUELSRM\plain\tab\fs18\f3\cf0\cb1 01/16/2006\plain\tab\fs18\f3\cf0\cb1 Binding study for Mu anti IL-1a,b DVD4-IG\plain\tab\fs18\f3\cf0\cb1 01/17/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 0.03{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.03{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 72\plain\tab\fs18\f3\cf0\cb1 A-920647.0\plain\tab\fs18\f3\cf0\cb1 recombinant mIL-1 beta{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1342908\plain\tab\fs18\f3\cf0\cb1 ANTI IL-1 ALPHA/BETA\plain\tab\fs18\f3\cf0\cb1 HUELSRM\plain\tab\fs18\f3\cf0\cb1 01/16/2006\plain\tab\fs18\f3\cf0\cb1 Binding study for Mu anti IL-1a,b DVD4-IG\plain\tab\fs18\f3\cf0\cb1 01/17/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 0.03{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.03{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 29\plain\tab\fs18\f3\cf0\cb1 A-926610.0\plain\tab\fs18\f3\cf0\cb1 TACI mIgG2a fusion{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1350410\plain\tab\fs18\f3\cf0\cb1 CD19\plain\tab\fs18\f3\cf0\cb1 HUELSRM\plain\tab\fs18\f3\cf0\cb1 12/01/2005\plain\tab\fs18\f3\cf0\cb1 in vivo studies\plain\tab\fs18\f3\cf0\cb1 12/01/2005\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1350410\plain\tab\fs18\f3\cf0\cb1 CD19\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 01/18/2006\plain\tab\fs18\f3\cf0\cb1 SEC Re-assay & compare w/ RH 07/20/05 \plain\tab\fs18\f3\cf0\cb1 01/18/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 65{\fs23\par}}\pard\plain\tx6240{\plain\tab\fs18\f3\cf0\cb1 run.{\fs20\par}}\pard\plain\sb81\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 67{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 42\plain\tab\fs18\f3\cf0\cb1 A-927819.0\plain\tab\fs18\f3\cf0\cb1 Y61 hu IgG1/L{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1351888\plain\tab\fs18\f3\cf0\cb1 ANTI-IL-12 (BACKUP)\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 12/14/2005\plain\tab\fs18\f3\cf0\cb1 Postive control for IL-1ab experiment.\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.2{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.2{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 95\plain\tab\fs18\f3\cf0\cb1 A-928040.0\plain\tab\fs18\f3\cf0\cb1 hu CXCL13/BLC/BCA-1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1352164\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 MANKOJA\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 SDS-PAGE standard for Western Blots\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1352164\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 ADAIRRM\plain\tab\fs18\f3\cf0\cb1 02/02/2006\plain\tab\fs18\f3\cf0\cb1 ligand for FLIPR assays\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.3{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.4{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 126\plain\tab\fs18\f3\cf0\cb1 A-928046.0\plain\tab\fs18\f3\cf0\cb1 mu CXCL13/BLC/BCA-1{\fs23\par}}\pard\plain\sb188\tx90\tqr\tx12960{\plain\tab\fs16\f4\cf0\cb1 Friday, March 10, 2006\plain\tab\fs16\f4\cf0\cb1 Page 3 of 5{\fs20\par}}{\page}\pard\plain\sb60\tx90\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12960{\plain\fs16\b\f2\cf0\cb2 ID\plain\tab\fs16\b\f2\cf0\cb2 Lot\plain\tab\fs16\b\f2\cf0\cb2 Project\plain\tab\fs16\b\f2\cf0\cb2 Requestor\plain\tab\fs16\b\f2\cf0\cb2 Requested\plain\tab\fs16\b\f2\cf0\cb2 Purpose\plain\tab\fs16\b\f2\cf0\cb2 Delivered\plain\tab\fs16\b\f2\cf0\cb2 Dispenser\plain\tab\fs16\b\f2\cf0\cb2 Amt(mg){\fs20\par}}\pard\plain\sb1\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1352174\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 02/23/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 02/23/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1352174\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 BOUSQPF\plain\tab\fs18\f3\cf0\cb1 01/18/2006\plain\tab\fs18\f3\cf0\cb1 cxcl13 methods development\plain\tab\fs18\f3\cf0\cb1 01/18/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1352174\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 ADAIRRM\plain\tab\fs18\f3\cf0\cb1 01/26/2006\plain\tab\fs18\f3\cf0\cb1 ligand for chemotaxis and FLIPR \plain\tab\fs18\f3\cf0\cb1 01/26/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.2{\fs23\par}}\pard\plain\tx6240{\plain\tab\fs18\f3\cf0\cb1 experiments{\fs20\par}}\pard\plain\sb21\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1352174\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 ADAIRRM\plain\tab\fs18\f3\cf0\cb1 02/02/2006\plain\tab\fs18\f3\cf0\cb1 ligand for chemotaxis and FLIPR assays\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.3{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.7{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 117\plain\tab\fs18\f3\cf0\cb1 A-928623.0\plain\tab\fs18\f3\cf0\cb1 SZ26-13C5.1A9{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1369582\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 GUJX\plain\tab\fs18\f3\cf0\cb1 02/13/2006\plain\tab\fs18\f3\cf0\cb1 V region sequencing by MS\plain\tab\fs18\f3\cf0\cb1 02/16/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1369582\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 MILLERX\plain\tab\fs18\f3\cf0\cb1 02/17/2006\plain\tab\fs18\f3\cf0\cb1 A549 Bioassay/BIAcore\plain\tab\fs18\f3\cf0\cb1 02/22/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 0.2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1369582\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 MILLERX\plain\tab\fs18\f3\cf0\cb1 03/01/2006\plain\tab\fs18\f3\cf0\cb1 BIAcore Receptor Binding Studies\plain\tab\fs18\f3\cf0\cb1 03/06/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 0.5{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1369582\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 WALLACX\plain\tab\fs18\f3\cf0\cb1 01/26/2006\plain\tab\fs18\f3\cf0\cb1 in-vivo asthma model\plain\tab\fs18\f3\cf0\cb1 01/27/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 10{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 12.7{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 137\plain\tab\fs18\f3\cf0\cb1 A-930993.0\plain\tab\fs18\f3\cf0\cb1 D2E7 F(ab¿)2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1355961\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 SCESNS\plain\tab\fs18\f3\cf0\cb1 03/08/2006\plain\tab\fs18\f3\cf0\cb1 D2E7 MOA\plain\tab\fs18\f3\cf0\cb1 03/09/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 93\plain\tab\fs18\f3\cf0\cb1 A-931300.0\plain\tab\fs18\f3\cf0\cb1 SZ26-9C11.3F6.3B12{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1369583\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 WALLACX\plain\tab\fs18\f3\cf0\cb1 02/03/2006\plain\tab\fs18\f3\cf0\cb1 Asthma model\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 10{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1369583\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 MILLERX\plain\tab\fs18\f3\cf0\cb1 02/17/2006\plain\tab\fs18\f3\cf0\cb1 A549 Bioassay/BIAcore\plain\tab\fs18\f3\cf0\cb1 02/22/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 0.2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1369583\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 HUBBASN\plain\tab\fs18\f3\cf0\cb1 02/24/2006\plain\tab\fs18\f3\cf0\cb1 IL-13 induced Asthma Model\plain\tab\fs18\f3\cf0\cb1 02/24/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 10{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 20.2{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 139\plain\tab\fs18\f3\cf0\cb1 A-931901.0\plain\tab\fs18\f3\cf0\cb1 C340 hu IgG1/K wt{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1372620\plain\tab\fs18\f3\cf0\cb1 ANTI-IL-12 (BACKUP)\plain\tab\fs18\f3\cf0\cb1 BAJARAC\plain\tab\fs18\f3\cf0\cb1 03/08/2006\plain\tab\fs18\f3\cf0\cb1 IL-12\plain\tab\fs18\f3\cf0\cb1 03/08/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.53{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.53{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 63\plain\tab\fs18\f3\cf0\cb1 A-932787.0\plain\tab\fs18\f3\cf0\cb1 XW25-2C4-4H8 Mu IgG1/K wt{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366530\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 GOESSC\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 In vivo immune response studies\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 10{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366530\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 ADAIRRM\plain\tab\fs18\f3\cf0\cb1 01/17/2006\plain\tab\fs18\f3\cf0\cb1 01/16/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 1.547{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366530\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 HSIEHCX\plain\tab\fs18\f3\cf0\cb1 02/14/2006\plain\tab\fs18\f3\cf0\cb1 Fab generation\plain\tab\fs18\f3\cf0\cb1 02/15/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 3{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366530\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 HSIEHCX\plain\tab\fs18\f3\cf0\cb1 02/02/2006\plain\tab\fs18\f3\cf0\cb1 Fab generation\plain\tab\fs18\f3\cf0\cb1 02/02/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 3{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366530\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 02/09/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 SWENSJ\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366530\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 BOUSQPF\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 CXCL13 assay development\plain\tab\fs18\f3\cf0\cb1 01/12/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 2{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 19.647{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 110\plain\tab\fs18\f3\cf0\cb1 A-932797.0\plain\tab\fs18\f3\cf0\cb1 XW25-6A2-2F10 Mu IgG1/k wt{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366521\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 02/09/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 SWENSJ\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366521\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 GOESSC\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 In vivo immune response studies\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 10{\fs23\par}}\pard\plain\sb96\tx90\tqr\tx12960{\plain\tab\fs16\f4\cf0\cb1 Friday, March 10, 2006\plain\tab\fs16\f4\cf0\cb1 Page 4 of 5{\fs20\par}}{\page}\pard\plain\sb60\tx90\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12960{\plain\fs16\b\f2\cf0\cb2 ID\plain\tab\fs16\b\f2\cf0\cb2 Lot\plain\tab\fs16\b\f2\cf0\cb2 Project\plain\tab\fs16\b\f2\cf0\cb2 Requestor\plain\tab\fs16\b\f2\cf0\cb2 Requested\plain\tab\fs16\b\f2\cf0\cb2 Purpose\plain\tab\fs16\b\f2\cf0\cb2 Delivered\plain\tab\fs16\b\f2\cf0\cb2 Dispenser\plain\tab\fs16\b\f2\cf0\cb2 Amt(mg){\fs20\par}}\pard\plain\sb1\tx540\tx1500\tx3915\tx4896\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366521\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 ADAIRRM\plain\tab\fs18\f3\cf0\cb1 01/17/2006\plain\tab\fs18\f3\cf0\cb1 01/16/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 1.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366521\plain\tab\fs18\f3\cf0\cb1 CXCL13\plain\tab\fs18\f3\cf0\cb1 BOUSQPF\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 CXCL13 methods development\plain\tab\fs18\f3\cf0\cb1 01/12/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 1.5{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 12.7{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 122\plain\tab\fs18\f3\cf0\cb1 A-933162.0\plain\tab\fs18\f3\cf0\cb1 8C11-1E10 F(ab')2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1358767\plain\tab\fs18\f3\cf0\cb1 ANTI-TNF ALPHA\plain\tab\fs18\f3\cf0\cb1 BARLOEH\plain\tab\fs18\f3\cf0\cb1 02/16/2006\plain\tab\fs18\f3\cf0\cb1 Anti-id immunogen\plain\tab\fs18\f3\cf0\cb1 02/24/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 138\plain\tab\fs18\f3\cf0\cb1 A-937316.0\plain\tab\fs18\f3\cf0\cb1 1D4.7 hu IgG1 mut (234 235)/K{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1372619\plain\tab\fs18\f3\cf0\cb1 ANTI-IL-12 (BACKUP)\plain\tab\fs18\f3\cf0\cb1 BAJARAC\plain\tab\fs18\f3\cf0\cb1 03/08/2006\plain\tab\fs18\f3\cf0\cb1 IL-12\plain\tab\fs18\f3\cf0\cb1 03/08/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.63{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.63{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 96\plain\tab\fs18\f3\cf0\cb1 A-939093.0\plain\tab\fs18\f3\cf0\cb1 11B11.2D2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1366541\plain\tab\fs18\f3\cf0\cb1 ANTI IL-13\plain\tab\fs18\f3\cf0\cb1 HUELSRM\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 SEC purification to remove aggragates\plain\tab\fs18\f3\cf0\cb1 02/06/2006\plain\tab\fs18\f3\cf0\cb1 HUELSR\plain\tab\fs18\f3\cf0\cb1 22.2768{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 22.2768{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 52\plain\tab\fs18\f3\cf0\cb1 A-940174.0\plain\tab\fs18\f3\cf0\cb1 Recombinant Murine IL-23{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367752\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 ZHONGSX\plain\tab\fs18\f3\cf0\cb1 01/06/2006\plain\tab\fs18\f3\cf0\cb1 immunization\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367752\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 QUINTLJ\plain\tab\fs18\f3\cf0\cb1 01/10/2006\plain\tab\fs18\f3\cf0\cb1 splenocyte assay\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367752\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 01/10/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367752\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 01/30/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 01/30/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367752\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 ZHONGSX\plain\tab\fs18\f3\cf0\cb1 01/06/2006\plain\tab\fs18\f3\cf0\cb1 immunization\plain\tab\fs18\f3\cf0\cb1 01/06/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 2{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367752\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 QUINNCM\plain\tab\fs18\f3\cf0\cb1 01/13/2006\plain\tab\fs18\f3\cf0\cb1 biotinylation\plain\tab\fs18\f3\cf0\cb1 01/12/2006\plain\tab\fs18\f3\cf0\cb1 PEREILX\plain\tab\fs18\f3\cf0\cb1 1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 5.3{\fs23\par}}\pard\plain\tx90\tx555\tx1860{\plain\fs18\f3\cf0\cb1 57\plain\tab\fs18\f3\cf0\cb1 A-940175.0\plain\tab\fs18\f3\cf0\cb1 Recombinant Human IL-23{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367754\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 01/10/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367754\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 QUINTLJ\plain\tab\fs18\f3\cf0\cb1 01/10/2006\plain\tab\fs18\f3\cf0\cb1 splenocyte assay\plain\tab\fs18\f3\cf0\cb1 01/11/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\tx540\tx1500\tx3915\tx4896\tx6240\tx9900\tx11211\tqr\tx12957{\plain\tab\fs18\f3\cf0\cb1 1367754\plain\tab\fs18\f3\cf0\cb1 IMMUNOSCIENCE \plain\tab\fs18\f3\cf0\cb1 CLABBAX\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 Biacore testing\plain\tab\fs18\f3\cf0\cb1 02/08/2006\plain\tab\fs18\f3\cf0\cb1 GIFFOKA\plain\tab\fs18\f3\cf0\cb1 0.1{\fs23\par}}\pard\plain\sb45\tqr\tx12960{\plain\tab\fs18\f3\cf0\cb1 0.3{\fs23\par}}\pard\plain\sb2269\tx90\tqr\tx12960{\plain\tab\fs16\f4\cf0\cb1 Friday, March 10, 2006\plain\tab\fs16\f4\cf0\cb1 Page 5 of 5{\fs20\par}}}